Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Neuraxis, INCNRXS · Entity 6994 | Director | August 13, 2026 | August 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Neuraxis, INC
Report date August 13, 2026 · Filed August 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 67,072 |
Reported balance
After 2026-08-13 transaction · row 1
1 source rowRow 1 · 2026-08-13 · Grant · Acquired 31,134 · Balance 67,072 F1: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2026 Filed Aug 17, 2026 22:28 UTC | Neuraxis, INC NRXS · Entity 6994 | GrantCommon Stock | 31,134 | $6.28 | $195,521.52 |
DisclosureSEC source: 0001493152-26-038821 · ownership.xml · nonDerivative · entry 1 Ferge Kristin A · CIK 0001343345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,072 F1 · shares: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer. F1 · price: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer. Read SEC document |
| January 22, 2026 Filed Jan 30, 2026 23:30 UTC | Neuraxis, INC NRXS · Entity 6994 | GrantCommon Stock | 21,598 | $4.63 | $99,998.74 |
DisclosureSEC source: 0001493152-26-004588 · ownership.xml · nonDerivative · entry 1 Ferge Kristin A · CIK 0001343345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,938 F1 · price: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer. Read SEC document |
| January 17, 2025 Filed Sep 10, 2025 10:32 UTC | Neuraxis, INC NRXS · Entity 6994 | GrantCommon Stock | 13,157 | $2.85 | $37,497.45 |
DisclosureSEC source: 0001641172-25-027019 · ownership.xml · nonDerivative · entry 1 Ferge Kristin A · CIK 0001343345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,340 F1 · price: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 19:18 UTC | Neuraxis, INC NRXS · Entity 6994 | GrantCommon Stock, par value $0.001 | 1,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-025972 · ownership.xml · nonDerivative · entry 1 Ferge Kristin A · CIK 0001343345 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,183 F1 · kind: These shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), were issued to Ms. Ferge pursuant to an Unrestricted Stock Award Agreement dated June 28, 2024 (the "Agreement"), by and between NeurAxis, Inc. (the "Company") and Ms. Ferge. Pursuant to the Agreement, as compensation for the services provided as a member of the Board of Directors of the Company by Ms. Ferge through March 31, 2024, the Company issued Ms. Ferge the number of shares of Common Stock as determined by dividing $3,287.67 by the closing price of the Common Stock on June 28, 2024, which was $2.78 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.